Anaphylactic shock infusion therapy


ABSTRACT. Anaphylactic shock is anaphylaxis with signs of critical organ hypoperfusion that threatens the patient’s life. For anaphylactic shock, the features of both distributive and hypovolemic shock are inherent. Distributive shock leads to the movement of fluid from the capillaries into the surrounding tissue, accompanied by inadequate perfusion of the tissues. The rapid recognition of anaphylaxis, the administration of epinephrine and the replacement of intravascular fluid are key factors in the successful outcome of the treatment of this potentially fatal event. The main principle that should be followed when carrying out infusion therapy of anaphylactic shock is the principle of small volume resuscitation (SVR), based primarily on the redistribution of endogenous fluid without the need for significant volumes of exogenous solutions. Hyperosmolar solutions used for SVR infusion therapy provide fluid return from the intercellular space to the vascular bed. The movement of fluid from the intercellular sector to the intravascular volume leads to an increase in the volume of circulating blood, contributes to the normalization of microcirculation and perfusion of tissues. SVR leads to an anti-shock effect due to a sharp increase in the intravascular volume of blood, and a decrease in edema improves microcirculation and perfusion of tissues and normalizes the water-electrolyte balance. Infusion therapy for anaphylactic shock is carried out by crystalloid solutions till hemodynamic stabilization. The choice of acceptable preparations for infusion varies among simple and balanced saline solutions, preparations based on polyhydric alcohols, taking into account the individual reaction of the patient to volume infusion.

Keywords: anaphylaxis, shock, infusion.


Gorovenko N. H., Gumeniuk N. I., Derkach N. N. Ispol’zovanie infuzionnyh preparatov dlja korrekcii metabolicheskogo acidoza [The use of infusion drugs to correct metabolic acidosis]. Ukrainian Chemotherapeutic Journal. 2008; 1-2 (22): 29-33.

Gumeniuk N. I., Kirkilevskiy S. I. Infuzionnaya terapiya. Teoriya i praktika [Infusion therapy. Theory and practice]. K.: Kniga plyus, 2004. 208 p.

Nakaz MOZ Ukraіni vіd 30.12.2015 № 916 “Pro zatverdzhennya ta vprovadzhennya mediko-tekhnologіchnih dokumentіv zі standartizacіі medichnoі dopomogi pri medikamentoznіj alergіі, vklyuchayuchi anafіlaksіyu” [Unified clinical protocol of emergency, primary, secondary (specialized) and tertiary (highly specialized) medical care «Medication allergy, including anaphylaxis»]. Asthma and Allergy. 2016; 3: 46-68.

Nedashkivskyy S. M., Babak S. I. , Dzyuba D. O., Tretyachenko S. O., Halushko O. A. Bahatoatomni spyrty. Chastyna 1. Manitol i sorbitol [Polyhydric alcohols. Part 1. Mannitol and sorbitol]. Hostri ta nevidkladni stany u praktytsi likarya. 2016; 1 (57): 9-12.

Feshchenko Y. I., Gumeniuk N. I. Infuzionnaja terapija v klinike vnutrennih boleznej [Infusion therapy in the clinic of internal medicine]. Ukrainian Chemotherapeutic Journal. 2008; 1-2 (22): 9-13.

Anaphylaxis vs. anaphylactoid reactions. Available at: (Last accessed: 28.04.2020).

Australian and New Zealand College of Anaesthetists (ANZCA) and Austral- ian and New Zealand Anaesthetic Allergy Group (ANZAAG) Perioperative Anaphylaxis Management Guidelines. Available at: au/documents/bp-anaphylaxis-2016.pdf (Last accessed: 13.05.2020).

Farooque S., Kenny M., Marshall S. Anaphylaxis to intravenous gelatin based solutions: a case series examining clinical features and severity. Anaesthesia. 2019; 74: 174-179. doi: 10.1111/anae.14497.

Hoste E., Maitland K., Brudney C. et al. for the ADQI XII Investigators Group. Four phases of intravenous fluid therapy: a conceptual model. British Journal of Anaesthesia. 2014; 113 (5): 740-747.

Hall J., Kress J., Schmidt G., Wood L. Principles of critical care (Internal medicine). 4th edition. Hardcover, 2015; 1392 p. ISBN-10: 0-07-173881-9.

Kim H., Kim S., Oh M., Kim J. Anaphylaxis induced by hydroxyethyl starch during general anesthesia. A case report. Korean J. Anesthesiol. 2012; 63 (3): 260-262. doi: 10.4097/kjae.2012.63.3.260.

Kolawole H., Marshall S., Crilly H., Kerridge R., Roessler P. Australian and New Zealand Anaesthetic Allergy Group / Australian and New Zea- land College of Anaesthetists Perioperative Anaphylaxis Management Guidelines. Anaesthesia and intensive care. 2017; 45 (2): 151-158. DOI: 10.1177/0310057X1704500204.

Krajewski M., Raghunathan K., Paluszkiewicz S., Schermer C., Shaw A. Meta-analysis of high-versus low-chloride content in perioperative and critical care fluid resuscitation. Br. J. Surg. 2015; 102 (1): 24-36. doi: 10.1002/bjs.9651.

Levy B., Fritz C., Tahon E., Jacquot A., Auchet T., Kimmoun A. Vasoplegia treatments: the past, the present, and the future. Crit. Care. 2018; 22 (1): 52. doi: 10.1186/s13054-018-1967-3.

Mandal M. Ideal resuscitation fluid in hypovolemia: the quest is on and miles to go! Int. J. Crit. Illn. Inj. Sci. 2016; 6 (2): 54-55. doi: 10.4103/2229- 5151.183020.

Messina A. et al. Fluids in shock. ICU Management & Practice. 2018; 18 (3): 154-157.

Moneret-Vautrin D., Morisset M., Flabbee J., Beaudouin E., Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. 2005; 60 (4): 443. DOI: 10.1111/j.1398-9995.2005.00785.x.

Moritz L., Ayus J. Maintenance intravenous fluids in acutely ill patients. N. Engl. J. Med. 2015; 373: 1350-1360. DOI: 10.1056/NEJMra1412877.

Pawankar R., Canonica G., Holgate S., Lockey R., Blaiss M. The WAO white book on allergy (update 2013). World Allergy Organization, 2013. ISBN: 061592915X, 9780615929156.

Rhodes A., Evans L., Alhazzani W. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017; 43 (3): 304-377. doi: 10.1007/s00134-017-4683-6.

Roselló S., Blasco I., García Fabregat L. et al. Management of infusion reactions to systemic anticancer therapy: ESMO clinical practice guidelines. Ann. Oncol. 2017; 28 (suppl. 4): iv100-iv118. doi: 10.1093/annonc/mdx216.

Schneider G., Kachroo S., Jones N. et al. A systematic review of validated methods for identifying anaphylaxis, including anaphylactic shock and angioneurotic edema, using administrative and claims data. Pharmacoepidemiology and drug safety. 2012; 21 (S1): 240-247. DOI: 10.1002/ pds.2327.

Semler M., Self W., Wanderer J. et al. Balanced crystalloids versus saline in critically ill adults. N. Engl. J. Med. 2018; 378 (9): 829-839. doi: 10.1056/ NEJMoa1711584.

Simons F., Ardusso L., Bilo M., Cardona V., Ebisawa M., El-Gamal Y. et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J. 2014; 7 (1): 9. doi: 10.1186/1939-4551-7-9.

Simons F., Ardusso L., Dimov V., Ebisawa M., El-Gamal Y., Lockey R., Sanchez-Borges M., Senna G., Sheikh A., Thong B., Worm M., World Allergy Organi- zation. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int. Arch. Allergy Immunol. 2013; 162 (3): 193-204. doi: 10.1159/000354543.

Smith N., Lopez R., Silberman M. Distributive shock [Updated 2019 Nov 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. Available at:

Standl T., Annecke T., Cascorbi I., Heller A., Sabashnikov A., Teske W. The nomenclature, definition and distinction of types of shock. Dtsch Arztebl Int. 2018; 115 (45): 757-768. doi: 10.3238/arztebl.2018.0757.

Turner P., Worm M., Ansotegui I. et al. Time to revisit the definition and clin- ical criteria for anaphylaxis? World Allergy Organ J. 2019; 12 (10): 100066. doi: 10.1016/j.waojou.2019.100066.

World Allergy Organization. Anaphylaxis: synopsis. Updated: April, 2019. Available at: cation/allergic-disease-resource-center/professionals/anaphylaxis-synopsis (Last accessed: 30.04.2020).

Zingerman C., Landow L., Wise R. Anaphylactoid reactions to dextran 40 and 70: reports to the United States Food and Drug Administration, 1969-2004. J. Vasc. Surg. 2006; 43: 1004-1009.

How to Cite
Gumeniuk, M. I., Gumeniuk, G. L., & Opimakh, S. G. (2020). Anaphylactic shock infusion therapy. Infusion & Chemotherapy, (2), 21-27.

Author Biographies

M. I. Gumeniuk, National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky NAMS of Ukraine, Kyiv

Gumeniuk Mykola Ivanovych
Leading Researcher, Department of Technologies of Treatment of Nonspecific Lung Diseases, National Institute of Phthisiology and Pulmonology named after
F. G. Yanovsky NAMS of Ukraine. MD.
10, M. Amosova st., Kyiv, 03038, Ukraine. ORCID iD:

G. L. Gumeniuk, National Medical Academy of Postgraduate Education named after P.L. Shupyk, Kyiv

Gumeniuk Galyna Lvivna
Professor of Department of Phthisiology and Pulmonology, National Medical Academy of Postgraduate Education named after P. L. Shupyk.
10, M. Amosova st., Kyiv, 03038, Ukraine. ORCID iD:

S. G. Opimakh, National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky NAMS of Ukraine, Kyiv

Opimakh Svitlana Henrikhivna
Researcher in National Institute of Phthisiology and Pulmonology named after F. G. Yanovsky NAMS of Ukraine. PhD.
10, M. Amosova st., Kyiv, 03038, Ukraine. ORCID iD:

Most read articles by the same author(s)